Introduction
In 1993 the World Health Organisation declared tuberculosis (TB) a global emergency 1 . Ten years on, it has been estimated that the global incidence rate of tuberculosis is growing at approximately 0.4%/year 2 . Of the world's new tuberculosis cases approximately 3% were attributed to multidrugresistant tuberculosis (MDR-TB) in 2000. Although multidrug-resistant tuberculosis may not be a problem globally, MDR-TB is at critical levels in many hot spots across the world 3 . The emergence of MDR-TB, the deadly link between TB and HIV infection, the problems of treatment expense and patient compliance, and the requirement to eliminate persistent infection emphasises the need for new anti-mycobacterial compounds to be developed 4 .
Mechanisms of drug resistance in Mycobacterium tuberculosis have been identified to all five first line anti-mycobacterial drugsisoniazid (INH), rifampin, pyrazinamide, ethambutol, and streptomycin. M. tuberculosis multiple resistance in these instances is conferred by a series of chromosomal mutations 5 . However, less is known about mechanisms of intrinsic/natural drug resistance in M. tuberculosis such as reduced cell wall permeability, efflux systems, or the expression of drug-inactivating enzymes. The poor action of many antibiotics, and the relative resistance of bacilli to drying, alkali and many chemical disinfectants has often been attributed to the low permeability of the unusual cell wall structure of mycobacteria 6 . In addition to the hydrophobic barrier of the mycobacterial cell wall, several genes encoding putative drug efflux systems have been identified in mycobacteria. The -4 -probable efflux protein efpA has been reported to be present in slow-growing pathogenic mycobacteria 7 . The efflux pump LfrA has been demonstrated in M. smegmatis to confer low-level resistance to fluoroquinolones 8 and to contribute to ethidium bromide resistance 9 , whereas the M. tuberculosis P55 multidrug efflux pump has been identified to confer aminoglycoside and tetracycline resistance 10 . Indeed, the H37Rv M. tuberculosis genome sequencing project revealed the presence of up to 24 members of the major facilitator superfamily of transporters, and over 80 putative members of the ABC-transporter family 11 . Of the ABC-transporter family, 21 export systems were defined in M. tuberculosis, many of which are implicated in the export of drugs and which may contribute to the innate resistance of mycobacteria to broad spectrum antibiotics 12 The advent of microarray technology has allowed the transcriptional profiles of bacteria to be examined in response to various stresses. The use of M.
tuberculosis microarrays was first reported to describe the induction of M. tuberculosis genes in response to INH treatment 15 . Genes were identified encoding proteins related to the mode of action of INH, such as acpM (coding for an acyl carrier protein), kasA and kasB (encoding -ketoacyl synthases).
Other genes most likely involved in the mycobacterial response to the toxicity of the drug were also highlighted -efpA (coding for a putative efflux protein), and aphC (alkyl hydroperoxide reductase, involved in the oxidative stress response). Microarray analysis of gene expression has also recently been used to predict the common functional category of unknown antimycobacterial drugs as part of a pipeline of drug discovery 16 .
We describe here the use of a gene-specific M. tuberculosis microarray to 
Microarray Data Analysis
Two measures of significance were applied to the normalised data set to identify differentially regulated genes (i) a minimum p value of 0.05 incorporating the cross-gene error model (GeneSpring) was set to discriminate genes significantly deviating from the 1:1 ratio (treated:untreated) which were then subjected to Benjamini and Hochberg correction to take into account multiple experiment testing and (ii) a one-way ANOVA (GeneSpring).
A technique of single spot replacement, SSR, (J. Bacon, personal communication) was also used to enhance the original data set. The unnormalised cDNA:genomic DNA ratios for each replicate under each condition were imported into Microsoft Excel. For each element on the microarray the individual ratio furthest from the median of the replicates was replaced with the mean of the remaining ratios. In this way the effect of extreme values was minimised from the data set. This SSR data set was then normalised as previously described, and subjected to two measures of significance: (i) the statistical group comparison (ANOVA); and (ii) the statistical package SAM -8 -(Significance Analysis of Microarrays, version 1.15 24 ) was used to identify genes differently expressed in the normalised data sets. A minimum fold change of 1.5 between control and drug-treated data sets, and a false discovery rate (FDR) of less than one (of the median) was used as a measure of significance.
The hypergeometric distribution was used to determine if particular functional categories of genes were enriched in response to each drug treatment. The hypergeometric p values were calculated as described by Boldrick et al., 2002 25 ; where N = 3924 the total number of genes in the population, A = the number of genes within each functional classification, x = the number of genes identified as up-regulated in response to each drug, and n = the total number of genes up-regulated after treatment by each anti-microbial compound.
Results
The transcriptional response of M. tuberculosis to each of the six antimicrobial agents was defined as the subset of genes identified as significantly differentially expressed in two or more statistical tests (described in the Table S1 .
Dissecting the transcriptional response of M. tuberculosis to the six drug compounds by functional classification (as described by Cole et al., 1998 11 ) revealed that the genes induced by drug treatment broadly represent most of the range of pathways that are present in M. tuberculosis. The hypergeometric distribution 25 was used to determine whether the enrichment of genes within a particular functional category in response to each drug treatment was significant (p value < 0.05). Table 1 shows that the number of genes within the functional categories of energy metabolism and chaperones/heat shock were significantly enhanced after treatment with each of 3 or more anti-microbial agents. The functional category of lipid metabolism was significantly enriched in response to INH and isoxyl treatment, as was the category of polyketide synthesis after treatment with SRI#967. Additionally, the proportion of genes involved in the metabolism of the cell envelope was significantly increased after treatment with SRI#221 and SRI#967 (Table 1) .
By comparing the similarities between the M. tuberculosis drug-induced expression profiles, a common response to anti-mycobacterial agents could be defined. A subset of 80 genes were identified which were significantly upregulated after treatment with 3 or more anti-microbial compounds (of a maximum 6). These genes are listed in Table 2 . Many of these common genes induced by exposure to anti-microbial compounds were involved in the mycobacterial stress response. Genes associated with DNA repair such as end (coding for a probable endonuclease) and recA (encoding recombinase A 26 ) were up-regulated; together with Rv3049c (a probable monoxygenase) and aphC (alkyl hydroperoxide reductase) expressed in response to oxidative stress 27 . Also over-expressed after drug treatment (>3 drugs) were gltA1 (a probable citrate synthase) and icl (isocitrate lyase) similar to changes in metabolism seen under stress conditions 28 . RNA polymerase sigma factors A and B were also induced, together with serine/threonine protein kinases B and G. sigB has been implicated in the M. tuberculosis response to a number of stress conditions 29 . The product of pknG is predicted to be a soluble protein (the transcription of which may be controlled by the redox status of the cell) which may be involved in glutamine uptake and which may be up-regulated under nitrogen-limiting conditions 30 . Additionally the putative nitrate/nitrite transporter narK2, the nitroreductase acg and the nitrate reductase narH were also identified to be induced. Indeed, five genes demonstrated to be part of the ACG (acr-coregulated gene) family were found to be up-regulated after exposure to anti-mycobacterial compounds -Rv1733c, narK2, Rv1738, Rv2005c, and acg 31 .
Many of the 'common' genes induced by drug treatment have been identified as part of the mycobacterial response to other stresses such as low oxygen 32 , heat shock 23 , acid shock 33 , detergent stress 34 , nitric oxide treatment 35 , phagocytosis 36 or nutrient/carbon starvation 37 /Hampshire et al., this issue.
Those genes, which have also been previously identified to be up-regulated in response to these other stresses are marked in Table 2 
Drug-specific expression responses
The expression profiles of M. tuberculosis treated with each of the six antimicrobial compounds were compared, by generating a similarity matrix detailing the number of overlapping genes between two drug treatments as a proportion of the possible maximum (Fig. 2) . The mycobacterial response to INH and isoxyl exposure was most similar as may be expected as both drugs target aspects of fatty acid and mycolic acid biosynthesis 17/18/19 . The expression profiles of M. tuberculosis treated with the compounds SRI#967 and SRI#9190 were also similar. Aspects of the mycobacterial response to individual drugs focusing on the possible action of the compounds is briefly presented below.
INH and Isoxyl
Both INH and isoxyl inhibit fatty acid and mycolic acid biosynthesis in M. tuberculosis 17/18/19 . INH has been demonstrated to target the enoyl-AcpM reductase InhA, a component of the fatty acid synthase -II (FAS-II) 39 . Isoxyl treatment inhibits mycolic acid and shorter-chain fatty acid synthesis leading to the hypothesis that isoxyl may act on other components of FAS-II 18 .
Interestingly, it has also recently been shown to target a delta-9 desaturase in mycobacteria 19 . Genes coding for enzymes involved in FAS-II were upregulated after exposure to both drugs: fabD (coding for a malonyl-CoA::acyl carrier protein (ACP) transferase), acpM (an acyl carrier protein), kasA and kasB (both -ketoacyl ACP synthases). These have been previously identified to be induced by INH, ethionamide and thiolactomycin treatment 15/16 . Interestingly amongst other fatty acid biosynthetic genes induced by isoxyl treatment alone was mabA, a gene coding for a -ketoacyl ACP reductase, which also belongs to the FAS-II system. The induction of mabA (which is transcriptionally linked to inhA in M. tuberculosis), after exposure to isoxyl, but not INH, may reflect differences in the mode of action of these two compounds. Further experiments such as the overexpression of mabA during isoxyl exposure may help to elucidate the primary target of isoxyl 40 . These genes cluster around the polyketide synthase pks2, responsible for the biosynthesis of the multi-methyl branched phthioceranic acids present in the sulpholipid complex lipids 42 . The induction of these gene clusters may be part of a compensatory network to minimise the anti-mycobacterial effects of SRI#221, may reflect the broad nature of SRI#221 action, or highlight the primary mode of SRI#221 action to be within shared basic lipid biosynthetic pathways.
Tetrahydrolipstatin

SRI#967 and SRI#9190
The mode of action of the anti-mycobacterial compounds SRI#967 and SRI#9190 are yet to be determined. The M. tuberculosis response to SRI#967 exposure includes the up-regulation of Rv0076c and Rv0077c. Rv0076c encodes a probable membrane protein, whereas Rv0077c codes for a possible oxidoreductase. Similarly, Rv0135c (a putative transcriptional regulator) and Rv0136 (belonging to the cytochrome P450 group of monoxygenases) were induced by SRI#9190 treatment alone. The induction of these two distinct clusters (on exposure to different anti-mycobacterial compounds) may be part of a similar oxidative stress response. The identification that these genes may play a role in the intrinsic resistance of M. tuberculosis to anti-microbial agents using microarray analysis enables more specific experimental strategies to be employed.
Of particular interest was a cluster of 4 genes which were significantly induced on exposure to both SRI#967 and SRI#9190. Rv3159c (encoding PPE53, a member of the PPE family), Rv3160c (a putative transcriptional regulator), Rv3161c (a probable dioxygenase) and Rv3162c (a possible integral membrane protein) were up-regulated on exposure to these compounds alone (none of these genes were induced by the other anti-microbial agents tested).
The probable dioxygenase Rv3161c is most similar to ring hydroxylating dioxygenases, so it likely that this enzyme is involved in the degradation of benzene ring structures (which SRI#967 and SRI#9190 both contain, Fig. 1 ).
Rv3160c and Rv3161c have recently been identified to be induced by triclosan treatment 16 . Triclosan (2,4,4´-trichloro-2-hydroxydiphenyl ether) contains two chlorinated benzene rings. This cluster of genes may therefore be induced on exposure to compounds containing halogenated benzene rings, this would explain the up-regulation of the cluster in response to SRI#967 and SRI#9190, but not to the benzene ring structures in isoxyl and SRI#221. This gene cluster may be induced as part of a response to render halogenated benzene compounds benign, so contributing to the natural resistance of M. tuberculosis to a range of anti-microbial agents.
Discussion
The response of M. tuberculosis to six antimicrobial compounds was determined by microarray analysis. The microarray expression data set was analysed using several statistical methods, the use of multiple statistical methods added extra depth to the interpretation of the data sets. Additionally, a single spot replacement strategy was used alongside the original data set to allow the maximum amount of information to be extracted from the data sets without significantly shifting the expression patterns. tuberculosis to antimicrobial agents. Microarray profiling of M. tuberculosis gene expression after exposure to drugs enables compounds of unknown mechanism of action to be classified into similarity groups, but in this study has not been helpful to elucidate the site of or mechanism of action. This would require complementary genetic and biochemical studies informed by microarray profiling. These gene lists are described in Supplementary Table S1 . The hypergeometric probabilities 25 
